Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.66 |
| ▸ | THRA | P10827 | 3/20 | 0.63 |
| ▸ | THRB | P10828 | 3/20 | 0.63 |
| ▸ | HRH2 | P25021 | 6/20 | 0.62 |
| ▸ | HRH1 | P35367 | 6/20 | 0.62 |
| ▸ | DGKA | P23743 | 1/20 | 0.60 |
| ▸ | MMP1 | P03956 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28315253 | 1.00 | L3MBTL1 (0.66) | L3MBTL1THRATHRBHRH2HRH1 | |
| SCHEMBL11440823 | 0.86 | L3MBTL1 (0.76) | L3MBTL1THRATHRBHRH2HRH1 | |
| SCHEMBL30552491 | 0.86 | HDAC8 (0.57) | L3MBTL1THRATHRBHRH2HRH1 | |
| SCHEMBL3829470 | 0.86 | L3MBTL1 (0.68) | L3MBTL1THRATHRBHRH2HRH1 | |
| SCHEMBL23726382 | 0.85 | L3MBTL1 (0.60) | L3MBTL1DGKATP53TSHR | |
| SCHEMBL8754539 | 0.84 | THRA (0.65) | L3MBTL1THRATHRBHRH2HRH1 | |
| SCHEMBL9075091 | 0.84 | THRA (0.68) | L3MBTL1THRATHRBHRH2HRH1 | |
| SCHEMBL16318691 | 0.84 | THRA (0.68) | L3MBTL1THRATHRBHRH2HRH1 | |
| SCHEMBL15519509 | 0.84 | THRA (0.68) | L3MBTL1THRATHRBHRH2HRH1 | |
| SCHEMBL5354673 | 0.84 | DGKA (0.66) | DGKATP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105997967-B | Compound and composition for treating cancer | 普罗米蒂克医药SMT有限公司 | 2019-08-23 | — | — | CN | disclosed |